Vext Science, Inc.
VEXT
CNSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.50% | 15.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.50% | 15.97% | |||
| Cost of Revenue | 1.94% | -8.05% | |||
| Gross Profit | -18.53% | 113.84% | |||
| SG&A Expenses | 5.33% | 27.89% | |||
| Depreciation & Amortization | -2.72% | 13.79% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.82% | 1.66% | |||
| Operating Income | -207.55% | 77.25% | |||
| Income Before Tax | -1,187.50% | 107.42% | |||
| Income Tax Expenses | -113.95% | 880.47% | |||
| Earnings from Continuing Operations | -77.81% | 55.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -77.81% | 55.67% | |||
| EBIT | -207.55% | 77.25% | |||
| EBITDA | -31.07% | 136.07% | |||
| EPS Basic | -76.67% | 55.56% | |||
| Normalized Basic EPS | -410.00% | 89.36% | |||
| EPS Diluted | -6.00% | 25.93% | |||
| Normalized Diluted EPS | -410.00% | 89.36% | |||
| Average Basic Shares Outstanding | 0.01% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||